The incidence and prevalence of ERF in children in the UK are relatively static at 8.0 and 47.7 per million population under the age of 15 years, respectively. The prevalence of ERF in children from the South Asian community is almost three times that of the White population whilst the incidence is over three times that of the White population and similar to the increase seen in the adult population. The high incidence and prevalence are related to the high incidence of inherited diseases which cause ERF in the South Asian community. ERF in children is more common in males than females (male to female ratio 1.54:1). This is due to a preponderance of males with renal dysplasia and obstructive uropathy causing ERF. For the South Asian patients, the gender ratio is 1:1 as the inherited diseases are mainly autosomal recessive. Renal dysplasia is the single most common cause of ERF in childhood, followed closely by glomerular disorders and then obstructive uropathy. The majority of prevalent paediatric ERF patients (76%) have a renal allograft. Of these, 28% are from living donations. The proportion of patients from ethnic minority groups with a functioning allograft is significantly smaller than that in the White population (P < 0.0001). Despite this, the rate of living related donation is no higher in the ethnic minority population. In prevalent patients PD is twice as commonly used as HD with the majority managed with automated PD. For patients at one year from starting RRT, 49% are on PD, 10% on HD and 41% have a transplant.
Introduction
Knowledge of the demography of the ERF population is important both for the planning of service provision and for the development of preventative treatment programmes. This article covers the demography of ERF in children in the UK and their current modality of ERF treatment.
Paediatric ERF population
The paediatric arm of the Renal Registry currently holds data on some 1800 patients who had ERF in childhood. A number of these patients have died and many have been transferred to adult units. The population of ERF patients being treated in paediatric units on 1st April 2005 stood at 768. This is a small fall on the number from 2004. The reasons for this probably lie with incomplete data returns from three units, together with variability of the population with the transfer of teenage patients to adult units. Table 13 .1 shows the prevalent population by gender and ethnicity together with the numbers who were under 18 years of age and 15 years of age on 1st April 2005. As in previous Reports, there are about 20 young people over the age of 18 years remaining in paediatric units. These patients are transferred between the age of 18 and 20 years. There are no patients over the age of 20 years in the current cohort. Reasons for delayed transfer include the management of specific paediatric comorbidities and concerns over growth, development and education. The distribution of the population with regard to gender and ethnicity was unchanged from previous reports. There remains a predominance of males and just over 17% come from ethnic minority backgrounds. Figure 13 .1 shows the size of the population under the age of 15 years from 1986 to 2005. The apparent growth in this population seen in 2004 has not been maintained but this will be due to some missing data from units with incomplete submissions together with some variability year on year in presentation rates. The overall trend has been that of a slowing of the initially sharp increase in the population. This is supported by the data on incidence and prevalence presented subsequently.
The age distribution of the population over a number of years is shown in Tables 13.2 and 13.3. The former gives the customary divisions by age and the latter shows the population divided into four year age bands for ease of comparison. Though there is year to year variability, the numbers have been fairly static of late, clearly showing a cessation of the rapid population growth seen after paediatric ERF treatment became available. Figure 13 .2 shows the data in Table 13 .3 graphically and clearly shows that over recent years there has been no significant change in the age distribution of the population.
The gender distribution of the paediatric ERF population is shown in Figure 13 .3. Throughout the age range, males predominate but there is a steady rise in the proportion of females in the population with increasing age.
Of the ethnic minority patients, the vast majority are of South Asian origin. The age and gender distributions of this cohort are somewhat different to that of the White population. This is secondary to the different causes of ERF in the South Asian community 1  16  18  13  14  10  12  14  2 -4  55  46  56  58  56  51  45  5 -9  150  151  146  147  141  166  157  10 -14  208  293  301  315  310  329  299  15 -19  253  274  259  256  244  253  Total <15 263  429  508  516  534  517  558  515  Total <20  761  790  793  773 802 768 and is dealt with in detail subsequently. Figure 13 .4. The difference in gender distribution between the White and South Asian paediatric ERF populations is shown in Figure 13 .5 which contrasts the proportion of the population in each age group who are male. In the under-the-age of 4-years group, 77% of White patients group are male. Thereafter, there is a fall in the proportion of males in the White population, with an increase in the proportion of males in the South Asian population, until in the young adults, both lie between 55 and 60%. There were only five Asian patients under age 4 so these have been removed from the graph.
Prevalence and take-on rate
Data on the UK population divided according to age and ethnic background was taken from the Office for National Statistics' website (www.statistics.gov.uk). Data for this report are based upon current population estimates which themselves are extrapolated from the United Kingdom Census of 2001. Table 13 .5 shows the prevalence of ERF per million childhood population for each age group. These figures have changed little since previous Reports [1-6] as one might expect from the stable population numbers. Figure 13 .6 shows this graphically, clearly demonstrating the steady rise in prevalence with patient age until the fall in the over 16-year-old group, secondary to transfer to adult units. The figures for prevalence of ERF in the UK are comparable with those presented in the USRDS and ANZDATA registries [7, 8] .
Whilst there is no mention of ethnicity in the most recent ANZDATA report the USRDS report does give an ethnic breakdown but not one which is specific to the paediatric age range. As the majority of the patients are adults and there are varying rates of glomerulonephritis, hypertensive and diabetic nephropathies amongst the different adult ethnic groups, it is impossible to extrapolate this published data to look at prevalence and ethnicity in children. As with previous reports from the UK paediatric registry the prevalence of ERF is much higher in the South Asian community, Demography and management of childhood established renal failure in the UK vii167 being almost three times that of the White population, whilst the prevalence of ERF in the Black population and those of other ethnic origins is a little below that of the White community. This is demonstrated in Figure 13 .7. The reasons for this distribution lie in the varying causes of ERF with ethnicity and are discussed subsequently. The take on rates of patients starting RRT has been assessed looking at a 5-year period to even out the peaks and troughs seen with annual data collection when relatively small numbers are being analysed. This is demonstrated well by the undulant picture shown by the ANZDATA incidence chart. Looking at take on rate as a mean of consecutive 5-year periods, there is clearly little change in the incidence of ERF in children. Overall, the incidence of ERF in children in the UK is very similar to that of the Australian, New Zealand and US cohorts. These data are shown in 4-year age bands in Table 13 .6 and graphically in Figure 13 .8. There is a nadir of presentation of ERF in the 4-8-year-old group following a peak in the first 4 years of life with the presentation of many children with obstructive uropathy and renal dysplasia. Following this there is a steady rise in incidence as the number of patients with glomerular diseases increases. As with the prevalence data, the take on rate of new patients with ERF in the South Asian community far outweighs that of the White community with an incidence per million childhood population 3.7 times that of the White population (Figure 13.9 ). This incidence figure will, over a number of years, lead to the proportion of the total population of children with ERF coming from the South Asian community rising still further. The distribution of the ethnic minority population (and consequently the ethnic minority children with ERF) around the UK is not evenly spread [6] . This has significant implications for resource management.
Causes of ERF in children
The causes of ERF have been analysed by looking at a total of 913 incident patients presenting with ERF before the age of 16 years, since the inception of the registry in 1996, for whom a primary diagnosis was stated. Diagnoses have been grouped into 12 bands. These are shown in Table 13 .7 with a further breakdown of each of the groupings in Tables 13.8-13.17. Renal dysplasia remains the single most common diagnostic group comprising almost a quarter of the total cohort. There is a male predominance in patients with renal dysplasia, and this together with the male contingent with obstructive uropathy from posterior urethral valves, accounts for the overall gender distribution of the paediatric ERF population. The gender distribution of each diagnostic group is shown in Figure 13 .10. Although there is no explanation for this, a high incidence of renal dysplasia in males has not only been noted in the UK registry reports but also in the NAPRTCS report [9] . Glomerular disease follows closely behind renal dysplasia, accounting for 22% of patients. Obstructive uropathy is the third most common cause accounting for 15%.
The nature and distribution of the diseases causing ERF in childhood have not changed significantly over the years that reports have been generated by the Registry. However, this will be due to the fact that a complete and expanding cohort has been used to look at this distribution. Certainly the information provided by ANZDATA suggests a similar distribution of causes if one excludes the 15-20-year-age group, which appears to be a complete cohort in ANZDATA and therefore dramatically expands the band of patients with glomerulonephritides. The USRDS data available does not give a specific diagnostic breakdown for children. The NAPRTCS report is more difficult to interpret as the analysis of transplant and dialysis patients is separate. Certainly it appears that for White and Hispanic patients, renal dysplasia leads in conjunction with obstructive uropathy. Unlike the UK data, glomerular diseases causing ERF appear less frequent in this population. This however, is offset by the high incidence of glomerular diseases causing ERF in the Black population. Differences in the patterns of primary pathology with ethnicity in the UK population are dealt with subsequently.
To investigate whether there has been any change in the pattern of primary pathology causing ERF in children over the period the Registry has been collecting data, the distribution of diagnoses have been compared within the 12 main classifications in those patients presenting between 1996 (when data collection began) and 1999, with those patients presenting between 2002 and 2005. These data are shown in Table 13 .18. There is no significant difference in the patterns of disease. The incidence of obstructive uropathy has fallen slightly and time will tell whether this is an ongoing trend. Reflux nephropathy has fallen and there has been a parallel rise in the incidence of ERF of uncertain aetiology. Knowing the difficulty in categorizing patients who present with small kidneys, either in or near ERF, it is possible that this simply represents variability in classification. The incidence of tubulo-interstitial diseases has risen. Again, only time will tell whether this is a true trend, however, it is something that may be expected given the rising South Asian population and the increased frequency of these pathologies in this ethnic group. As alluded to above and published in previous reports from the Registry, there is a significant difference in the pattern of diseases causing ERF in different ethnic groups. This is shown in Table 13 .19. Whilst for the White population renal dysplasia predominates followed closely by glomerular diseases, in the South Asian population glomerular diseases predominate with a lower incidence of renal dysplasia. Tubulo-interstitial disorders, metabolic diseases and congenital nephrotic syndrome are much more common in the South Asian community. The overall difference in the distribution of diseases between the White and South Asian populations is highly significant (chi-square ¼ 40.2, P < 0.0001). Interpretation of the distribution of diseases in the Black population and those from other ethnic backgrounds is more difficult because of the small numbers. Black patients with glomerular diseases contribute over 50% of the cohort and renal dysplasia is much less common with only occasional cases of other disorders appearing. Certainly data from NAPRTCS would suggest that this is not an unrepresentative pattern of disease.
Much of the difference between the patterns of disease in the South Asian patients compared to the White cohort can be explained by the high incidence of autosomal recessive inherited disorders in this population. Table 13 .20 shows the pattern of inheritance of the primary cause of ERF in 913 patients presenting after 1996 and starting ERF before the age of 16 years for whom both details of primary diagnosis and ethnicity were available. Overall, 190 patients (20.8%) had diseases with a clear inheritance link, showing the major contribution of genetic problems to childhood ERF. Of these, the vast majority (90.5%) were autosomal recessive diseases with just a small number of dominant, sex linked and mitochondrial disorders. These of course do not include patients with diseases that probably do have a strong genetic component that has not yet been clearly defined, such as isolated renal dysplasia. The proportion of each ethnic group with inherited disease as a cause of ERF is shown in Figure 13 .11. This clearly shows the excess of inherited disease both in those of South Asian origin and in those of 'Other' origin. Consanguineous marriage is more common in both of these groups compared with the White population. Although the small numbers of patients in the 'Other' group make valid statistical analysis difficult, the increased proportion of inherited disease in the South Asian group compared with the White population is very significant (P < 0.0001, Fisher's exact test). The age distribution of the paediatric ERF population is determined by both the survival of patients and the age of presentation with ERF. This in turn is often dependent upon the aetiology of ERF. The effect of diagnosis upon the population age distribution is shown in Figures 13.12, 13 .13 and 13.14 subsequently. For each of these figures panel A shows the percentage of patients in a designated diagnostic group presenting in each age group, whilst panel B shows the percentage of patients in each age group belonging to that diagnostic group. Thus, for patients with renal dysplasia, 32% present with ERF in the first 4 years of life and 32% present between the ages of 12 and 16 years whilst the remaining third present in the intervening 8 years.
The proportion of patients with renal dysplasia as a cause of ERF in each age group, account for 34% of those in the first 4 years of life but only 20% of those between the ages of 12 and 16 years because other causes of ERF have become more frequent in this latter age group. The pattern for obstructive uropathy is virtually identical to that for renal dysplasia. As with renal dysplasia, virtually all patients will have been born with their problem. The distributions of both these groups show the combined effect of the severity of the initial problem and the subsequent rate of decline of GFR with the stresses of growth and hyper-perfusion glomerulopathy. Reflux nephropathy rarely causes ERF in the first 8 years of life and just over one-third present between 8 and 12 years of life with almost 60% entering ERF between the age of 12 and 16 years. Even so, reflux nephropathy only accounts for 11% of patients between the ages of 12 and 16 years with ERF. The addition of patients with renal dysplasia and reflux nephropathy together leads to a block accounting for a little under or over 30% of patients in each age group. In both conditions there is a high incidence of vesico-ureteric reflux and in both conditions there is likely to be congenital renal dysplasia. In view of the reduced frequency of urinary tract infections and clinical pyelonephritis in the older age groups, hyper-perfusion glomerulopathy is likely to play a major part in both conditions in determining the speed and timing of the decline into ERF. It is most likely therefore that reflux nephropathy and renal dysplasia share common origins. Glomerular diseases are rare in early childhood and 75% of children with these diseases will enter ERF beyond the age of 8 years.
As glomerular diseases are the most common cause of ERF in Black children this explains the age distribution of this cohort. Whilst this is a small group within the UK, this observation is important with regard to the development of services in developing countries. Those with a predominantly Black population where consanguineous marriage is rare can expect their paediatric ERF population to come from the older childhood groups. This will limit the potential size of the paediatric unit, particularly if transfer to adult services is at a much younger age than is the norm in the UK and Europe. The same data for the main disease groups with inherited diseases are shown in Figures 13.13 A and B. As one might expect, diseases such as congenital nephrotic syndrome and polycystic kidney disease peak in the first 4 years of life, whilst the tubular and metabolic disorders peak later in childhood.
The final four groups are shown in Figures 13.14 A and B. Numerically these very different conditions account for only a small percentage of patients, both overall and in any one age band.
Current treatment of paediatric ESRF patients
Of the 768 patients, data on modality on 1st April 2005 were available for 684 (89%). The distribution of modalities has changed little since previous reports with 76% of patients having a functioning allograft and for the remainder, peritoneal dialysis being a more common treatment than haemodialysis. For those with allografts, over two-thirds have cadaveric grafts with 21% of the total population (28% of those with allografts) having a graft from a living donor. For those on peritoneal dialysis the vast majority are receiving automated PD with few centres using CAPD (Figure 13.15) .
The proportion of engrafted patients, whose graft has come from a living (usually related) donor, rather than a cadaveric donor, is slowly but steadily increasing (Figure 13.16 ). This, in the face of a stable ERF population with a stable proportion whose management is with an allograft, highlights the shortage of suitable cadaveric organs, the need to use living donation to maintain the proportion of engrafted patients and the change in medical practice in the UK with a greater emphasis being placed upon the benefits of living donation. The distribution of RRT modalities divided according to ethnic origin is shown in Figure 13 .17. Whilst 80% of White patients have a functioning allograft only 63% of South Asian patients and 42% of Black patients have one. These populations therefore have proportionately larger numbers on dialysis. For all groups, peritoneal dialysis is the most frequent dialysis modality employed. The difference between ethnic groups in the distribution of treatment modalities is significant (P < 0.0001, Chi-squared ¼ 22.2). Part of the explanation for the lower transplantation rates in ethnic minority groups is the lower rate of living donation. Certainly the proportion of South Asian patients with an allograft from a living donor is significantly lower than the proportion of White patients with one (P ¼ 0.0466). This difference loses its significance if all ethnic minorities are compared with the White population. The ethnic minority population have a different distribution of tissue types and blood groups to the White population who form the vast majority of the donor pool. In these circumstances it is inevitable that there will be fewer offers of well matched cadaveric allografts for ethnic minority patients than White patients. In these circumstances only an increase in the number of live donors in the ethnic minority groups will allow the proportion with a functioning allograft in these groups to rise to that of the White population.
An important aspect of ERF management is treatment modality change with time. Figure 13 .18 shows the distribution of patients according to whether or not their treatment modality had changed since the previous data collection in 2004. Clearly for the majority there was no change. Just under 11% of the cohort had had a change in treatment modality during the year whilst 77% did not. The remainder were new patients with no previous annual record.
For those who had had no change over the previous year, the vast majority (84%) had a functioning allograft. Nine percent were maintained on peritoneal dialysis and 7% on haemodialysis (Figure 13 .19).
For those who changed treatment modality over the course of the year the reason in most was because they were transplanted. Sixty-one percent of this cohort received an allograft and the distribution of these between patients on peritoneal and haemodialysis was appropriate for the numbers on each modality. Nineteen percent lost grafts and started dialysis, 75% of these started peritoneal dialysis. Fourteen percent of the cohort moved from peritoneal to 
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Grafted from PD Grafted from HD Graft to PD Graft to HD PD to HD HD to PD Recovered haemodialysis whilst only 5% of the cohort moved in the opposite direction. One patient recovered enough renal function to stop dialysis (Figure 13 .20).
The distribution of RRT modalities in April 2005 of the 81 patients starting ERF management during that year is shown in Figure 13 .21. As expected, the single largest group accounting for 49% of the cohort were those on peritoneal dialysis. Just 10% were on haemodialysis whilst 41% had a functioning allograft. A proportion of this latter group would have had pre-emptive grafts whilst others will have received an allograft during the first year as a second treatment modality.
Conclusions
The incidence and prevalence of ERF in children in the UK has changed little over recent years. Similarly, analyses of the causes of ERF in childhood shows little change over the past decade. After an initial steep growth following the commencement of RRT services for children in the UK, the size of the paediatric ERF population is now relatively static. As with most paediatric and adult RRT studies there is a male predominance. In the paediatric population this is secondary to both the large proportion of patients with posterior urethral valves as a cause of ERF and the predominance of males with renal dysplasia as a cause of ERF.
The striking data is the high incidence and prevalence of ERF in the South Asian community in the UK. This is in part due to a high incidence of autosomal recessive inherited diseases causing ERF in this population. This could potentially lead not only to further growth of the ERF population over the next two decades, but also to a change in the pattern of disease causing ERF in the UK childhood population in addition to equalization of the gender distribution of ERF.
The commonest RRT modality for children with ERF is transplantation, with 76% of the population having a functioning allograft. The paucity of cadaveric organs has led to an increase in the proportion of these patients with an allograft from a living donor. Living donation is less frequent in the South Asian community who by virtue of their tissue types and that of the cadaveric donor pool, are also less likely to receive a graft. This could lead to a growing number of patients on dialysis as the ethnic minority population grows. For those on dialysis the majority are managed with peritoneal dialysis and the vast majority of these patients receive APD rather than CAPD.
